The prevention and treatment of metabolic syndrome and high-risk obesity
- 1 September 2006
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Cardiology
- Vol. 21 (5), 479-485
- https://doi.org/10.1097/01.hco.0000240586.76344.f5
Abstract
The prevalence of obesity is increasing at an alarming rate, and the obesity epidemic is driving the epidemic in type 2 diabetes. High-risk obesity is characterized by abdominal obesity with evidence of abnormal glucose and lipid metabolism, and a state of heightened inflammation.With increasing body weight, lipid accumulation occurs not only in adipose tissue, but in other organs as well. This 'lipotoxicity' in liver, muscle, islets, and elsewhere may account for many of the features of the metabolic syndrome. Adipose tissue produces many proteins, some of which are inflammatory cytokines, and others of which are antiinflammatory or which improve insulin sensitivity.The treatment of obesity requires the identification of the high-risk patient, and the institution of lifestyle measures with a long-term outlook, and an avoidance of heavily marketed fads. Current research will likely lead to improved medications in the future.Keywords
This publication has 61 references indexed in Scilit:
- Prevalence of Overweight and Obesity in the United States, 1999-2004Published by American Medical Association (AMA) ,2006
- Increased plasma adiponectin in response to pioglitazone does not result from increased gene expressionAmerican Journal of Physiology-Endocrinology and Metabolism, 2006
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trialThe Lancet, 2005
- Pioglitazone improves insulin sensitivity through reduction in muscle lipid and redistribution of lipid into adipose tissueAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Reduction in Visceral Adiposity is Highly Related to Improvement in Vascular Endothelial Dysfunction among Obese Women: An Assessment of Endothelial Function by Radial Artery Pulse Wave AnalysisYonsei Medical Journal, 2005
- Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 DiabetesThe New England Journal of Medicine, 2004
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.JCI Insight, 1995
- The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.JCI Insight, 1995
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience, 1993
- Pathogenesis of NIDDM: A Balanced OverviewDiabetes Care, 1992